10.5001  -0.03 (-0.28%)		07-31 16:00
Open: 10.795 High: 10.795 Volume: 809		Pre. Close: 10.53 Low: 10.5 Market Cap: 61(M)

Short term
Mid term
Targets	6-month :	13.03	1-year :	13.98
Resists	First :	11.16	Second :	11.97
Pivot price	10.58
Supports	First :	9.85	Second :	8.2
MAs	MA(5) :	10.54	MA(20) :	10.54
	MA(100) :	10.32	MA(250) :	11.59
MACD	MACD :	0	Signal :	0
%K %D	K(14,3) :	27.6	D(3) :	26
RSI	RSI(14): 50.3
52-week	High :	14.76	Low :	8.56

Price has closed below its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.
[ DXR ] has closed above bottom band by 40.1%. Bollinger Bands are 47.1% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 13 bars. This is a sign that the market may be about to initiate a new trend.

If tomorrow:	Open lower	Open higher
High:	10.82 - 10.87	10.87 - 10.92
Low:	10.35 - 10.43	10.43 - 10.48
Close:	10.4 - 10.51	10.51 - 10.6

Based in Oak Ridge, Tennessee, Daxor Corporation is a medical technology enterprise founded in 1971. The company specializes in blood volume measurement, developing and commercializing the BVA-100 Blood Volume Analyzer. This diagnostic instrument offers a precise, objective method for quantifying a patient's blood volume status and composition, comparing these metrics against their unique physiological norms. It is utilized across a wide spectrum of medical and surgical contexts. Prior to May 1973, the organization operated under the name Idant Corporation.

Thu, 30 Jul 2026
Daxor Launches Blood Testing Lab in Eastern Kansis - marketscreener.com

Thu, 30 Jul 2026
Daxor Corporation Initiates Outpatient Blood Volume Analysis Program in Kansas - marketscreener.com

Wed, 29 Jul 2026
DXR|Daxor Corp|Price:10.510|Chg%:-0.140 - TradingKey

Wed, 29 Jul 2026
Daxor Corporation Launches Outpatient Blood Volume Analysis Program at Kansas Healthcare Facility - Quiver Quantitative

Wed, 29 Jul 2026
A Kansas Facility Gets Daxor Blood-Volume Results in 24 Hours - Stock Titan

Wed, 29 Jul 2026
Daxor Broadens Outpatient Footprint with Initiation of ezBVA Lab Diagnostic Services in Kansas - GlobeNewswire

Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.	Outperform
Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).	Neutral
Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.	Underperform
Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.	Outperform
Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.	Outperform
Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.	Outperform

Exchange: NASDAQ
Sector: Healthcare
Industry: Medical - Instruments & Supplies
Shares Out	0 (M)
Shares Float	0 (M)
Held by Insiders	5.84e+006 (%)
Held by Institutions	2.51e+006 (%)
Shares Short	0 (K)
Shares Short P.Month	0 (K)

EPS	26690
EPS Est Next Qtrly	0
EPS Est This Year	0
EPS Est Next Year	0
Book Value (p.s.)	1.63
Profit Margin	34 %
Operating Margin	359.1 %
Return on Assets (ttm)	-9 %
Return on Equity (ttm)	660.5 %
Qtrly Rev. Growth	22.4 %
Gross Profit (p.s.)	0.26
Sales Per Share	-0.01
EBITDA (p.s.)	-0.01
Qtrly Earnings Growth	0 %
Operating Cash Flow	0 (M)
Levered Free Cash Flow	0 (M)

PE Ratio	0
PEG Ratio	0
Price to Book value	6.4
Price to Sales	-641851
Price to Cash Flow	3196.58

Dividend	1470
Forward Dividend	2080
Dividend Yield	13999.8%
Dividend Pay Date	Invalid DateTime.
Ex-Dividend Date	Invalid DateTime.